These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18064573)

  • 1. Recent advances on pathogenesis and therapies in systemic sclerosis.
    Yazawa N; Fujimoto M; Tamaki K
    Clin Rev Allergy Immunol; 2007 Oct; 33(1-2):107-12. PubMed ID: 18064573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunopathogenesis of fibrosis in systemic sclerosis.
    Brown M; O'Reilly S
    Clin Exp Immunol; 2019 Mar; 195(3):310-321. PubMed ID: 30430560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of chemokines in leukocyte recruitment and fibrosis in systemic sclerosis.
    Hasegawa M; Sato S
    Front Biosci; 2008 May; 13():3637-47. PubMed ID: 18508461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunobiology of systemic sclerosis.
    Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
    Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bleomycin-induced scleroderma model: what have we learned for scleroderma pathogenesis?
    Yamamoto T
    Arch Dermatol Res; 2006 Feb; 297(8):333-44. PubMed ID: 16402183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
    Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
    Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology of systemic sclerosis.
    Artlett CM
    Front Biosci; 2005 May; 10():1707-19. PubMed ID: 15769660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleroderma - new aspects in pathogenesis and treatment.
    Balbir-Gurman A; Braun-Moscovici Y
    Best Pract Res Clin Rheumatol; 2012 Feb; 26(1):13-24. PubMed ID: 22424190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B lymphocytes in systemic sclerosis: Abnormalities and therapeutic targets.
    Yoshizaki A
    J Dermatol; 2016 Jan; 43(1):39-45. PubMed ID: 26782005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon dysregulation in Systemic Sclerosis.
    Skaug B; Assassi S
    Cytokine; 2020 Aug; 132():154635. PubMed ID: 30685202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes in Systemic Sclerosis: Messengers Between Immune, Vascular and Fibrotic Components?
    Colletti M; Galardi A; De Santis M; Guidelli GM; Di Giannatale A; Di Luigi L; Antinozzi C
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487964
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of metabolism in the pathogenesis of systemic sclerosis.
    Zhu H; Chen W; Liu D; Luo H
    Metabolism; 2019 Apr; 93():44-51. PubMed ID: 30586574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic roles of B lymphocytes in systemic sclerosis.
    Yoshizaki A
    Immunol Lett; 2018 Mar; 195():76-82. PubMed ID: 29307688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic sclerosis: current views of its pathogenesis.
    Derk CT; Jimenez SA
    Autoimmun Rev; 2003 Jun; 2(4):181-91. PubMed ID: 12848944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic sclerosis].
    Ihn H
    Nihon Rinsho; 2009 Mar; 67(3):519-22. PubMed ID: 19280926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopathogenesis of Juvenile Systemic Sclerosis.
    Stevens AM; Torok KS; Li SC; Taber SF; Lu TT; Zulian F
    Front Immunol; 2019; 10():1352. PubMed ID: 31293569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunopathological disturbances in systemic sclerosis].
    Gindzieńska-Sieśkiewicz E; Klimiuk PA; Kowal-Bielecka O; Sierakowski S
    Pol Merkur Lekarski; 2005 Dec; 19(114):800-3. PubMed ID: 16521427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
    Yoshizaki A
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell abnormalities in systemic sclerosis with a focus on Th17 cells.
    Brembilla NC; Chizzolini C
    Eur Cytokine Netw; 2012; 23(4):128-39. PubMed ID: 23360781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of progressive systemic sclerosis.
    Haustein UF; Herrmann K; Böhme HJ
    Int J Dermatol; 1986 Jun; 25(5):286-93. PubMed ID: 3522447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.